Literature DB >> 16133585

Serum RANTES, MIP-1alpha, and MCP-1 levels in Behçet's disease.

Huseyin T E Ozer, Eren Erken, Ramazan Gunesacar, Oguz Kara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 16133585     DOI： 10.1007/s00296-004-0519-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  10 in total

Review 1.  Switching gears during T-cell maturation: RANTES and late transcription.

Authors:  B D Ortiz; P J Nelson; A M Krensky
Journal:  Immunol Today       Date:  1997-10

2.  Cytokines in Behçet's disease.

Authors:  N Sayinalp; O I Ozcebe; O Ozdemir; I C Haznedaroğlu; S Dündar; S Kirazli
Journal:  J Rheumatol       Date:  1996-02       Impact factor: 4.666

3.  Activation of dual T cell signaling pathways by the chemokine RANTES.

Authors:  K B Bacon; B A Premack; P Gardner; T J Schall
Journal:  Science       Date:  1995-09-22       Impact factor: 47.728

4.  Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

Authors:  J L Mege; N Dilsen; V Sanguedolce; A Gul; P Bongrand; H Roux; L Ocal; M Inanç; C Capo
Journal:  J Rheumatol       Date:  1993-09       Impact factor: 4.666

5.  RANTES and MIP-1alpha activate stats in T cells.

Authors:  M Wong; E N Fish
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

6.  Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever.

Authors:  C Notarnicola; M N Didelot; F Seguret; J Demaille; I Touitou
Journal:  Genes Immun       Date:  2002-02       Impact factor: 2.676

7.  Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Authors:  Toshikatsu Kaburaki; Yujiro Fujino; Hidetoshi Kawashima; Guillermo Merino; Jiro Numaga; Jun Chen; Kouji Matsushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-23       Impact factor: 3.117

8.  Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.

Authors:  M A Frassanito; R Dammacco; P Cafforio; F Dammacco
Journal:  Arthritis Rheum       Date:  1999-09

9.  Diagnosis of familial Mediterranean fever by a molecular genetics method.

Authors:  S Eisenberg; I Aksentijevich; Z Deng; D L Kastner; Y Matzner
Journal:  Ann Intern Med       Date:  1998-10-01       Impact factor: 25.391

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307
  10 in total
  4 in total

1.  Promoter -2518 single nucleotide polymorphism of monocyte chemoattractant protein-1 is associated with clinical severity in Behçet's disease.

Authors:  Seong-Kyu Kim; Won-Cheoul Jang; Young-Chang Ahn; Sang-Hyun Lee; Shin-Seok Lee; Jin-Wuk Hur
Journal:  Inflamm Res       Date:  2012-04-03       Impact factor: 4.575

Review 2.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

3.  Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy.

Authors:  Antonio Puccetti; Piera Filomena Fiore; Andrea Pelosi; Elisa Tinazzi; Giuseppe Patuzzo; Giuseppe Argentino; Francesca Moretta; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-04-24       Impact factor: 4.818

4.  MicroRNA Expression Profiling in Behçet's Disease.

Authors:  Antonio Puccetti; Andrea Pelosi; Piera Filomena Fiore; Giuseppe Patuzzo; Claudio Lunardi; Marzia Dolcino
Journal:  J Immunol Res       Date:  2018-05-07       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.